CAMP4 Therapeutics (CAMP) vs Nature's Sunshine Products (NATR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
CAMP4 Therapeutics (CAMP) has outperformed Nature's Sunshine Products (NATR) over the past year, losing 0.5% versus a loss of 14.8%. CAMP4 Therapeutics is the larger company by market cap ($236.6 million vs $222.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAMP | NATR |
|---|---|---|
| Share price | $3.77 | $12.64 |
| Market cap | $236.58M | $222.41M |
| 1-day change | +1.89% | +0.56% |
| YTD return | -38.50% | -41.43% |
| 1-year return | -0.53% | -14.82% |
| 5-year return | — | -17.76% |
| P/E ratio (TTM) | — | 12.51 |
| Forward P/E | — | 10.28 |
| EPS (TTM) | $-2.32 | $1.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.75 | $28.14 |
| 52-week low | $2.86 | $12.31 |
| Distance from 52-week high | -51.35% | -55.08% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +180.37% | +141.30% |
| Average volume | 278.11K | 161.81K |
| Shares outstanding | 62.75M | 17.60M |
| Employees | 48 | 806 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CAMP has outperformed NATR by 14.3 percentage points over the past year.
About CAMP4 Therapeutics
CAMP stock →Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders.
Health Care · Biotechnology: Pharmaceutical Preparations · 48 employees
About Nature's Sunshine Products
NATR stock →Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.
Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees
CAMP vs NATR FAQ
Which is bigger, CAMP4 Therapeutics or Nature's Sunshine Products?
CAMP4 Therapeutics (CAMP) is larger, with a market capitalization of $236.58M compared with $222.41M for Nature's Sunshine Products (NATR).
Which stock has performed better over the past year, CAMP or NATR?
CAMP returned -0.53% over the past 12 months, compared with -14.82% for NATR (price return, excluding dividends). Past performance does not predict future results.
Are CAMP4 Therapeutics and Nature's Sunshine Products in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.